Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.
about
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingClinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a reviewApplication of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tumor response to gamma knife radiosurgery.Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.Functional imaging in adult and paediatric brain tumours.Advanced MR imaging of gliomas: an updateDiffusion-weighted MRI as a biomarker for treatment response in gliomaApparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Relationship between Apparent Diffusion Coefficients and MR Spectroscopy Findings in High-Grade Gliomas.Preoperative Grading of Astrocytic Supratentorial Brain Tumors with Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion CoefficientImaging of central nervous system tumors in children: advances and limitations.Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas.Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.Value of Minimum Apparent Diffusion Coefficient on Magnetic Resonance Imaging as a Biomarker for Predicting Progression of Disease Following Surgery and Radiotherapy in Glial Tumors from a Tertiary Care Center in Northern IndiaIsolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma.Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme.Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancyGlioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity.Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancerEvaluation of apparent diffusion coefficient thresholds for diagnosis of medulloblastoma using diffusion-weighted imaging.Use of apparent diffusion coefficient values for diagnosis of pediatric posterior fossa tumorsCan MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma.Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative gradingClinical utility of quantitative imaging.ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.Elevated citrate in pediatric astrocytomas with malignant progression.Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical methodCorrelation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma.Diffusion-weighted imaging-based probabilistic segmentation of high- and low-proliferative areas in high-grade gliomasEarly Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models.Differentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imagingDiffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.
P2860
Q26796223-81F2ACAC-F53B-4CFD-B2C4-09E10D163852Q26864367-3AC817F5-8677-4B52-A023-26B0B984378BQ30457918-464E2DF5-F925-4061-A2F6-C38A8DE47AF9Q30571373-EF9007DA-8FBF-4FE4-9F65-19FA7854E2CFQ30577397-36CB008D-E11F-4F13-AC2D-89ACB957511BQ30655700-56241ED2-9DAC-4441-8AF9-7F601FF3A8FAQ30660991-3EE6CF06-3840-46CD-9895-6A0C6196C5D1Q30730091-66F264EC-59D7-49C0-B995-3D3235BF326FQ30907831-20412136-DD1E-4429-A66A-9519E6B75AB8Q31077412-15214AC7-8AB3-4ACC-A56C-3A71384FF0AFQ31142723-37747ABC-7156-45D9-BE56-2E027CA0DA5DQ33379510-52981165-6917-49B2-ABE3-46528203CD64Q33399304-F488BEC6-7702-4DD9-AF09-C92D7E2F8730Q33530806-5F9AB801-877D-4701-9CBC-05066D4D60BEQ33594897-E00DF40C-304D-4A3D-9AF6-75402D5CCEC3Q33693500-D69444F4-4C58-48D8-8699-EB8DC2633F8DQ33751294-3A58B4C7-500C-46BF-ABE8-D8F56A7DAD10Q33812703-C5695832-FA62-44D1-85BD-E9048F292778Q33824804-F220A2A7-B32A-4B3E-9E5F-D744E923A83FQ33828114-107C17B0-22BC-41AA-A319-392EB8E2F998Q33974708-8B8E288F-C9CB-4EA4-BE3C-895A5CD50910Q34277159-36C04179-73DC-4C74-A3B4-1D27C666A80EQ34323153-07431F69-ED4A-4864-99A7-89C529477FB8Q34369621-1435A4F0-B4BF-4CC4-BF47-E89F998128C2Q34369717-7C0CA216-44E9-4B27-A3FE-19EA407E8345Q34471323-ED70DF3F-3AFF-4B00-BC4C-6FDE9FF2B1A9Q34511741-4E7FAE49-348C-40F8-9EF7-9B98F76AE384Q34590141-1FB9D0E7-9135-4647-A31A-B3847C494C9EQ34656915-508D2026-0431-4192-8DF9-69482C1B56D3Q34712780-F016AFB1-C611-4DAF-8D09-A3FCF7730E3CQ35225263-743CAC66-F8CA-453C-9DE8-5CE6AE888519Q35296992-BAAADFEE-6A18-4910-BDCD-580193B59771Q35718063-0D232F44-6908-42D7-9694-3D76CC651C32Q35720769-6E61182C-2D7B-4CB2-A4E4-1E58108E8A44Q35909492-F175137B-DAEB-4C00-869A-2F23494D1786Q36164058-3F0A094F-143A-42FD-8B7F-5CE7CD170B1DQ36335591-C4B3E141-D841-46EA-A345-0E75AA2875DAQ36367421-3DC991AA-E328-4690-8310-7DF54610B0FAQ36561792-038680DB-F43F-4F63-AD26-C4625F1A8B45Q36785131-CFF1984C-E74A-44F0-A69E-93265BC0844A
P2860
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@ast
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@en
type
label
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@ast
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@en
prefLabel
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@ast
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@en
P2093
P1433
P1476
Malignant astrocytic tumors: c ...... iction of grade and prognosis.
@en
P2093
Akihiro Sato
Atsushi Umetsu
Mika Watanabe
Shoki Takahashi
Shuichi Higano
Shunji Mugikura
Takayuki Yamada
Toshihiro Kumabe
P304
P356
10.1148/RADIOL.2413051276
P407
P577
2006-10-10T00:00:00Z